KRYS vs TSM
Krystal Biotech Inc (KRYS) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
TSM (TSM) common stock.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
TSM does not have a complete income-statement cache yet.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. TSM currently screens at market cap $0.
Not investment advice. Open the KRYS and TSM stock pages for the full models.
Not investment advice.